NEA Partners 13, Limited Partnership's Net Worth
$0
Who is NEA Partners 13, Limited Partnership?
NEA Partners 13, Limited Partnership does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., TESARO, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, BuzzFeed, Inc., Sprout Social, Inc., Clovis Oncology, Inc., BOX INC, Coursera, Inc., Dermira, Inc., PhaseBio Pharmaceuticals Inc, GLYCOMIMETICS INC, Epizyme, Inc., MINERVA SURGICAL INC, Roka BioScience, Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., and CVENT INC.
SEC CIK
NEA Partners 13, Limited Partnership's CIK is 0001460752
Past Insider Trading and Trends
2020 was NEA Partners 13, Limited Partnership's most active year for acquiring shares with 4 total transactions. NEA Partners 13, Limited Partnership's most active month to acquire stocks was the month of October. 2020 was NEA Partners 13, Limited Partnership's most active year for disposing of shares, totalling 4 transactions. NEA Partners 13, Limited Partnership's most active month to dispose stocks was the month of October. 2020 saw NEA Partners 13, Limited Partnership paying a total of $0.00 for 12,889,668 shares, this is the most they've acquired in one year. In 2020 NEA Partners 13, Limited Partnership cashed out on 12,889,668 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cloudflare, Inc. (NET) Snapshot price: $75.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.76M |
Nov 11
| |||
Form 4
| -31.92% | -1.30M |
—
|
—
| 2.76M |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.06M |
May 19
| |||
Form 4
|
∞
| 4.06M |
—
|
—
| 4.06M |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.86% | -1.78M |
$0.15 | -$262,264.02 | 4.86M |
Oct 25
| |||
Form 4
|
∞
| 6.64M |
$5.00 |
—
| 6.64M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ra Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.14M |
—
|
—
|
0
|
Apr 2
| |||
Form 4
| +11.75% | 645.16K |
$15.50 | $9,999,995.50 | 6.14M |
Dec 14
| |||
Form 4
| +57.31% | 2M |
$6.00 | $12,000,000.00 | 5.49M |
Feb 16
| |||
Form 4
|
∞
| 3.49M |
$11.76 | -$5,655.00 | 3.49M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sprout Social, Inc. (SPT) Snapshot price: $27.08
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -44.78% | -2.50M |
—
|
—
| 3.08M |
Nov 13
| |||
Form 4
| -38.14% | -3.44M |
$27.50 | -$94,650,765.00 | 5.58M |
Aug 17
| |||
Form 4
|
∞
| 9.02M |
—
|
—
| 9.02M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLYCOMIMETICS INC (GLYC) Snapshot price: $0.1596
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.09M |
$8.00 |
—
| 4.09M |
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |